Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jul 25, 2017
Document Date
Jul 23, 2017
Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.